Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gelesis Inc.

www.gelesis.com

Latest From Gelesis Inc.

Execs On The Move, October 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

PureTech Health: Putting The “Z” In IP Commercialisation

IP commercialization may be all the rage for company creation in the UK, but it remains comparatively unknown in the US. Daphne Zohar of Boston-based PureTech Health talks to START-UP about her firm’s approach to creating and developing life science businesses.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, May 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Research/Analytical, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April 2015.

BioPharmaceutical Medical Device

Venture Funding Deals, May 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Gelesis Inc.
  • Senior Management
  • Yishai Zohar, CEO
    Robert Armstrong, CBO
    Hassan Heshmati, MD, CMO
  • Contact Info
  • Gelesis Inc.
    Phone: (617) 482-2333
    500 Boylston St., Ste. 1600
    Boston, MA 02116
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register